- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Congress Must Act for Cannabis Patients! Pass Medical Cannabis Legislation NOW! Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Reports 2021 State of the States Medical Cannabis in America Cannabis and Cannabis Resin- Critical Review Preparation Document Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit
- News News
- Join Join
By Todd R. Hansen for the Daily Republic
FAIRFIELD — California, one of the original eight states to legalize medical cannabis use, received a “B+” in the 2017 annual report by Americans for Safe Access.
Overall, the organization said there is still a lot of work to do, as none of the 44 states that allow medical marijuana use received an “A” grade. However, the number of states receiving a “B” or higher went from 11 to 19.
“Medical cannabis laws are moving in a positive direction, but only a handful of the 44 medical cannabis states are truly meeting the needs of patients, and there are still six states where cannabis remains completely illegal for patients,” Steph Sherer, executive director of Americans for Safe Access, said in a statement released with the annual report.
The grades are based on a formula that reviews the rights of patients, legal constraints and overall accessibility to medical cannabis. California also received a “B+” grade in 2016, the first year the report came out. Americans for Safe Access was formed in 2002.
“In short, we’re seeing a lot of progress, but the fight is far from over. As of 2017, no state cannabis laws are within the ‘A’ range,” Sherer said in the statement. “Only a small minority of states currently include ASA’s criteria of protections and rights that we believe all patients should be afforded under the law.”
The report is not broken down by regions or counties within a state. Solano County has limited access as Vallejo is the only city in the county where medical marijuana can be legally accessed. The city has 10 retail dispensaries.
California’s highest grading (97) came in the categories of “Access” and “Functionality,” while its lowest grading (59) was given for “Product Safety,” the report states.
The poor grade does not mean the marijuana is not safe, according to a written response to a question by the Daily Republic. Instead, Americans for Safe Access said California was docked points on several regulatory fronts.
Those included not requiring training for employees covering state and federal law, or scientific and medical information about cannabis; not requiring adverse event and recall programs; not requiring documentation and protocols for workplace cleaning and sanitation; lack of guidelines on pesticide labeling; and not requiring laboratory method validation according to standards equal to American Herbal Pharmacopoela cannabis studies.
The report, which includes an extensive amount of information about medical cannabis and how it’s governed in various states, also claims that there has never been a death caused by medical cannabis use.
When asked about statistics that show increases in fatal accidents in several states in which the driver tested positive for marijuana, a written response attributed to Dr. Jahan Marcu, stated: “These kinda [sic] of accidents usually always involve multiple substances. It is rare in a fatal car crash that only marijuana is detected. Most drivers who test for cannabis in fatal crashes usually have high levels of alcohol or other drugs, which has been the case well before adult cannabis use programs existed.”